The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
Open accessAbstract
Plasma net cholesteryl ester (CE) transfer and optimum cho- lesteryl ester transfer protein (CETP) activity were determined in primary hypertriglyceridemic (a = 11) and normolipidemic (a = 15) individuals.The hypertriglyceridemic group demon- strated threefold greater net CE transfer leading to enhanced accumulation of CE in VLDL.This increased net transfer was not accompanied by a change in CETP activity.In normolipide- mia, but not in hypertriglyceridemia, net CE transfer correlated with VLDL triglyceride (r = 0.92, P < 0.001).In contrast, net CE transfer in hypertriglyceridemia, but not in normolipide- mia, correlated with CETP activity (r = 0.73, P < 0.01).Correc- tion of hypertriglyceridemia with bezafibrate reduced net CE transfer towards normal and restored the correlation with VLDL triglyceride (r = 0.90, P < 0.005) while suppressing the correlation with CETP activity.That net CE transfer depends on VLDL concentration was confirmed by an increase ofnet CE transfer in normolipidemic plasma supplemented with purified VLDL.Supplementation of purified CETP to normolipidemic plasma did not stimulate net CE transfer.In contrast, net CE transfer was enhanced by addition of CETP to both plasma supplemented with VLDL and hypertriglyceridemic plasma.Thus, in normal subjects, VLDL concentration determines the rate of net CE transfer.CETP becomes rate limiting as VLDL concentration increases, i.e, in hypertriglyceridemia. (J.Clin.Invest.1991.88:2059-2066.)Key words: cholesteryl ester transfer protein * very low density lipoprotein -high density lipoprotein -cardiovascular disease * reverse cholesterol trans- port MO.Bezafibrate (2-[4-[2-[(4-chlorobenzoyl)amino]-ethyl]phenoxy]-2methylpropanoic acid) was obtained from Boehringer Mannheim (for- merly MCP Pharmaceuticals), Livingstone, Scotland. Cholesteryl Ester Transfer in Hypertriglyceridemia 2059
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hepatic lipase and cholesterol ester transfer protein contribute to the remodeling processes; whether hepatic lipase or cholesterol ester transfer protein has the predominant effect on the size and density of LDL and HDL particles depends on the triglyceride content of very low-density lipoproteins (VLDL) (27,28).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 862
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
PLASMA LIPID TRANSFER PROTEINS
Tall, A. R. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 470
Self-citationPlasma lipid transfer proteins.
Tall, A. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38819-2 · Cited by 377
Agellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X., Shelanski, S. A., Breslow, J. L., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99088-5 · Cited by 297
Gordon, D. J., Knoke, J. D., Probstfield, J. L., Superko, H. R., & Tyroler, H. A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1217 · Cited by 289
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
“limiting for the transfer of triglyceride from VLDL to HDL in hypertriglyceridemia, but not normotriglyceridemia (108).”
BackgroundEvaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
Cholesteryl Ester Transfer Protein
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 868
Postprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Durrington, P. N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14234-1 · Cited by 316
Attie, A., Kastelein, J. J. P., & Hayden, M. R. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31498-x · Cited by 286
Borggreve, S. E., Vries, R. D., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 277
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277
Noone, E., Roche, H. M., Nugent, A. P., & Gibney, M. J. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002615 · Cited by 240
“CETP is a key enzyme which regulates reverse cholesterol transport, catalysing the reciprocal transfer of TAG and cholesteryl ester between HDL and VLDL. VLDL-TAG is an important determinant of CETP activity (Mann et al. 1991).”
BackgroundDubois, C., Beaumier-Gallon, G., Juhel, C., Armand, M., Portugal, H., Pauli, A.-M., Borel, P., Latge, C., & Lairon, D. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.31 · Cited by 218
Heterogeneity at theCETPGene Locus
Kuivenhoven, J. A., de Knijff, P., Boer, J. M. A., Smalheer, H. A., Botma, G.-J., Seidell, J. C., Kastelein, J. J. P., & Pritchard, P. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.3.560 · Cited by 210
Apolipoproteins: metabolic role and clinical biochemistry applications
Dominiczak, M. H., & Caslake, M. J. (2011) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011111 · Cited by 238
Murakami, T., Michelagnoli, S., Longhi, R., Gianfranceschi, G., Pazzucconi, F., Calabresi, L., Sirtori, C. R., & Franceschini, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1819 · Cited by 201
Dullaart, R. P. F., Sluiter, W. J., Dikkeschei, L. D., Hoogenberg, K., & van Tol, A. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00987.x · Cited by 195
Guérin, M., Bruckert, É., Dolphin, P. J., Turpin, G., & Chapman, M. J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.763 · Cited by 195
Lagrost, L. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90047-7 · Cited by 192
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.
Hannuksela, M. L., Marcel, Y. L., Kesäniemi, Y. A., & Savolainen, M. J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41437-3 · Cited by 192
The nicotinic acid receptor–a new mechanism for an old drug
Karpe, F., & Frayn, K. N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16359-9 · Cited by 186
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
Offermanns, S. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.008 · Cited by 183
Pownall, H. J., Brauchi, D., Kilinç, C., Osmundsen, K., Pao, Q., Payton-Ross, C., Gotto, A. M., & Ballantyne, C. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00301-3 · Cited by 179
“In contrast, in hypertriglyceridemia, CETA correlated with endogenous CETA activity [16].”
Backgroundvan der Hoorn, J. W. A., de Haan, W., Berbée, J. F. P., Havekes, L. M., Jukema, J. W., Rensen, P. C. N., & Princen, H. M. G. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171363 · Cited by 172
Dachet, C., Poirier, O., Cambien, F., Chapman, J., & Rouis, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.507 · Cited by 168
Postprandial lipemia and cardiovascular disease
Hyson, D. A., Rutledge, J. C., & Berglund, L. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0033-y · Cited by 160
“In the postprandial state, similar to that of hypertriglyceridemic subjects, it is postulated that the extent of exchange may be determined by particle residence time in the circulation [ 67 ].”
BackgroundGoff, W. L., Guérin, M., & Chapman, M. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.10.001 · Cited by 148
Bruce, C., Sharp, D. S., & Tall, A. R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33876-1 · Cited by 147
“Mann et al. (3) have suggested that in normolipidemic individuals CETP is in excess, so that cholesteryl ester transfer rates are determined by plasma triglyceride concentrations, while in hypertriglyceridemic patients, because CETP is at limiting concentrations, transfer rates are determined by…”
InfluentialDurrington, P. N., Mackness, M., Bhatnagar, D., Julier, K., Prais, H., Arrol, S., Morgan, J., & Wood, G. N. I. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00003-3 · Cited by 145
Miesenböck, G., Hölzl, B., Föger, B., Brandstätter, E., Paulweber, B., Sandhofer, F., & Patsch, J. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116222 · Cited by 144
Studies of a targeted risk reduction intervention through defined exercise (STRRIDE)
Kraus, W. E., TORGAN, C. E., Duscha, B. D., Norris, J. M., Brown, S. A., Cobb, F. R., Bales, C. W., Annex, B. H., Samsa, G. P., Houmard, J. A., et al. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200110000-00025 · Cited by 144
Hayek, T., Azrolan, N., Verdery, R. B., Walsh, A., Chajek‐Shaul, T., Agellon, L. B., Tall, A. R., & Breslow, J. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116683 · Cited by 133
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00111-7 · Cited by 131
“Elevated plasma levels of triglyceride-rich lipoproteins are important in accelerating cholesteryl ester transfer [8,42,43], as supported by the lack of difference in CET after exclusion of subjects with high triglyceride levels from the present analysis.”
BackgroundGENETICS OF LIPOPROTEIN ABNORMALITIES ASSOCIATED WITH CORONARY HEART DISEASE SUSCEPTIBILITY
Breslow, J. L. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.233 · Cited by 128
Ginsberg, H. N., Jones, J., Blaner, W. S., Thomas, A., Karmally, W., Fields, L., Blood, D. K., & Begg, M. D. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1829 · Cited by 128
Tholstrup, T., Sandström, B., Bysted, A., & Hølmer, G. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.198 · Cited by 120
Dullaart, R. P. F., Hoogenberg, K., Dikkeschei, B. D., & van Tol, A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1581 · Cited by 115
“-(6)'(9)'(31) For instance, elevations in VLDL-TG may enhance the net mass transfer of CE out of HDL.(31) It is unlikely that this effect was operating in our study subjects because TG levels were similar in smokers and nonsmokers.”
BackgroundTholstrup, T., Ehnholm, C., Jauhiainen, M., Petersen, M., Høy, C., Lund, P., & Sandström, B. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.564 · Cited by 111
“In healthy subjects, VLDL concentrations determine the rate of net CE transfer (45).”
BackgroundThe Impact of Postprandial Lipemia in Accelerating Atherothrombosis
Roche, H. M., & Gibney, M. J. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700504 · Cited by 110
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
Asztalos, B. F., Swarbrick, M. M., Schaefer, E. J., Dallal, G. E., Horvath, K. V., Ai, M., Stanhope, K. L., Austrheim-Smith, I. T., Wolfe, B. M., Ali, M., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p900015 · Cited by 108
Cox, C., Mann, J. I., Sutherland, W. H. F., Chisholm, A. W., & Skeaff, M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41497-x · Cited by 108
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1998) · Diabetologia · doi:10.1007/s001250051009 · Cited by 107
Barter, P. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2029 · Cited by 107
Lipoprotein disorders in diabetes mellitus
Brown, W. V. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30180-8 · Cited by 106
Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus
Bagdade, J. D., Lane, J. D., Subbaiah, P. V., OTTO, M., & Ritter, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90177-v · Cited by 106
Fielding, C. J., Havel, R., Todd, K., Yeo, K. E., Schloetter, M., Weinberg, V., & Frost, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117705 · Cited by 114
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
Asztalos, B. F., Swarbrick, M. M., Schaefer, E. J., Dallal, G. E., Horvath, K. V., Ai, M., Stanhope, K. L., Austrheim-Smith, I. T., Wolfe, B. M., Ali, M. R., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900015-jlr200 · Cited by 102
Carr, M. C., Ayyobi, A. F., Murdoch, S. J., Deeb, S. S., & Brunzell, J. D. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013284.47317.95 · Cited by 100
Effect of Alcohol on Lipids and Lipoproteins in Relation to Atherosclerosis
Hannuksela, M. L., Liisanantti, M. K., & Savolainen, M. J. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795529 · Cited by 97
Tatò, F., Vega, G. L., Tall, A. R., & Grundy, S. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.112 · Cited by 97
Moulin, P., Gb, A., Ginsberg, H., & Tall, A. R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41339-2 · Cited by 97
Dubois, C., Armand, M., Azaı̈s-Braesco, V., Portugal, H., Pauli, A.-M., Bernard, P., Latge, C., Lafont, H., Borel, P., & Lairon, D. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.3.374 · Cited by 95
Sahebkar, A., Simental‐Mendía, L. E., Watts, G. F., Șerban, M.-C., & Banach, M. (2017) · BMC Medicine · doi:10.1186/s12916-017-0787-7 · Cited by 93
“The main mechanisms of action of fibrates are induction of lipoprotein lipolysis [31], induction of hepatic fatty acid uptake and reduction of hepatic triglyceride production [32, 33], enhancement of hepatic removal of LDL particles [34], reduction of plasma triglyceride-rich lipoproteins [35], and elevation of HDL pr…”
BackgroundWang, X., Driscoll, D. M., & Morton, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1814 · Cited by 90
Cassader, M., Gambino, R., Musso, G., Depetris, N., Mecca, F., Cavallo‐Perin, P., Pacini, G., Rizzetto, M., & Pagano, G. (2001) · Lipids · doi:10.1007/s11745-001-0822-5 · Cited by 88
Androgen deficiency and atherosclerosis: The lipid link
Traish, A. M., Abdou, R. Y., & Kypreos, K. E. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.003 · Cited by 84
Brites, F. D., Bonavita, C. D., Geitere, C. D., Cloës, M., Delfly, B., Yael, M. J., Fruchart, J., Wikinski, R. L. W., & Castro, G. R. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00452-9 · Cited by 83
“…normotriglyceridemic subjects and this elevation was not accompanied by an increment in CETP mass. Similarly, Murakami et al. [44] and Mann et al. [45] found that the net transfer of cholesteryl esters between endogenous lipoproteins was higher in samples from hypertriglyceridemic patients than…”
BackgroundTinker, L. F., Parks, E. J., Behr, S. R., Schneeman, B. O., & Davis, P. A. (1999) · Journal of Nutrition · doi:10.1093/jn/129.6.1126 · Cited by 83
Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol
Föger, B., Ritsch, A., Doblinger, A., Wessels, H., & Patsch, J. R. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1430 · Cited by 81
Masucci-Magoulas, L., Moulin, P., Jiang, X., Richardson, H., Walsh, A., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117832 · Cited by 79
“However, since hypertriglyceridemia is usually associated with decreased HDL levels due to CETP-mediated lipid exchange (37), it might be anticipated that the hypertriglyceridemia would produce a decrease in HDL cholesterol concentration in animals with normal plasma CETP activity.”
BackgroundForrester, J. S., Makkar, R., & Shah, P. K. (2005) · Circulation · doi:10.1161/01.cir.0000160860.36911.bd · Cited by 80
de Vries, R., Perton, F. G., Dallinga‐Thie, G. M., van Roon, A. M., Wolffenbuttel, B. H. R., van Tol, A., & Dullaart, R. P. F. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3554 · Cited by 79
“In comparison, a previous in vitro study (24) has shown that variation in the plasma CETP level only affects net cholesteryl ester mass transfer from HDL to VLDL at high plasma triglyceride concentrations.”
BackgroundA high-density lipoprotein-mediated drug delivery system
Mo, Z., Ren, K., Liu, X., Tang, Z., & Yi, G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.030 · Cited by 75
LDL and HDL enriched in triglyceride promote abnormal cholesterol transport
Skeggs, J. W., & Morton, R. E. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100431-jlr200 · Cited by 73
“In most individuals, plasma TG levels, not CETP concentrations, are rate limiting to this remodeling process ( 9 ).”
BackgroundBerglund, L., Oliver, E. H., Fontanez, N., Holleran, S., Matthews, K. A., Roheim, P. S., Ginsberg, H. N., Ramakrishnan, R., & LeFevre, M. L. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.992 · Cited by 71
“In normolipidemic subjects, VLDL concentrations have been reported to be rate-limiting for the net transfer of cholesterol esters from HDL to VLDL, whereas cholesteryl ester transfer protein concentrations are suggested to be more important in hypertriglyceridemia (53, 54).”
BackgroundPostprandial lipoprotein metabolism, genes and risk of cardiovascular disease
López-Miranda, J., Pérez-Martínez, P., Marin, C., Moreno, J., Gómez, P., & Perez-Jimenez, F. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217894.85370.c2 · Cited by 81
Björkegren, J., Karpe, F., Milne, R. W., & Hamsten, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32522-0 · Cited by 72
Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients
Tatò, F., Vega, G. L., & Grundy, S. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.56 · Cited by 72
Borggreve, S. E., Hillege, H. L., Wolffenbuttel, B. H. R., de Jong, P. E., Bakker, S. J. L., van der Steege, G., van Tol, A., & Dullaart, R. P. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0182 · Cited by 71
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid
Pike, N. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27160 · Cited by 71
Cholesteryl ester transfer protein and its plasma regulator
Morton, R. E. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199908000-00006 · Cited by 70
Guérin, M., Dolphin, P. J., Talussot, C., Gardette, J., Berthézène, F., & Chapman, M. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1359 · Cited by 70
Nagano, M., Yamashita, S., Hirano, K., Ito, M., Maruyama, T., Ishihara, M., Sagehashi, Y., Oka, T., Kujiraoka, T., Hattori, H., et al. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200024-jlr200 · Cited by 69
“This is true especially in the hypertriglyceridemic subjects ( 9 ).”
BackgroundBagdade, J. D., Dunn, F. L., Eckel, R. H., & Ritter, M. C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.1933 · Cited by 68
Current concepts in triglyceride metabolism, pathophysiology, and treatment
Abourjaili, G., Shtaynberg, N., Wetz, R. V., Costantino, T. G., & Abela, G. S. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.014 · Cited by 67
“Increases in TG and VLDL cause an increase in cholesterol ester transfer protein activity, which induces a shift in production from HDL and IDL to LDL cholesterol formation [7].”
BackgroundWilliams, P. T., Krauss, R. M., Stefanick, M. L., VRANIZAN, K. M., & Wood, P. D. (1994) · Metabolism · doi:10.1016/0026-0495(94)90210-0 · Cited by 66
Bhatnagar, D., Durrington, P. N., Channon, K. M., Prais, H., & Mackness, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90220-o · Cited by 66
Colhoun, H. M., Scheek, L. M., Rubens, M. B., van Gent, T., Underwood, S. R., Fuller, J., & van Tol, A. (2001) · Diabetes · doi:10.2337/diabetes.50.3.652 · Cited by 65
“This lack of independence is consistent with the hypothesis that accelerated exchange of lipids between VLDL and HDL is part of the pathway by which triglycerides exert their atherogenic effect (31).”
ResultKakko, Tamminen, Päivänsalo, Kauma, Rantala, Lilja, Reunanen, Kesäniemi, & Savolainen (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00595.x · Cited by 65
Circadian variation of postprandial lipemia
Romon, M., Fur, C. L., Lebel, P., Edmé, J.-L., Fruchart, J., & Dallongeville, J. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.934 · Cited by 63
“input of LDL and an increased transfer of cholesterol ester from HDL to TRL ( 34 ).”
BackgroundVakkilainen, J., Jauhiainen, M., Ylitalo, K., Nuotio, I. O., Viikari, J. S. A., Ehnholm, C., & Taskinen, M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31489-9 · Cited by 63
Unusual high-density lipoprotein subclass distribution during late pregnancy
Silliman, K., Tall, A. R., Kretchmer, N., & Forte, T. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90156-i · Cited by 61
Lagrost, L., Florentin, E., Guyard‐Dangremont, V., Athias, A., Gandjini, H., Lallemant, C., & Gambert, P. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1388 · Cited by 61
Hsu, L., Ko, Y., Hsu, K., Ko, Y.-H., & Lee, Y. (2001) · Human Genetics · doi:10.1007/s00439-001-0640-z · Cited by 60
Schwab, U., Maliranta, H. M., Sarkkinen, E. S., Savolainen, M. J., Kesäniemi, Y. A., & Uusitupa, M. I. J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90044-x · Cited by 59
Duvillard, L., Pont, F., Florentin, E., Gambert, P., & Vergès, B. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00473-6 · Cited by 59
Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL.
Lagrost, L., Gambert, P., & Lallemant, C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.8.1327 · Cited by 59
Cholesteryl ester transfer protein and atherosclerosis
Inazu, A., Koizumi, J., & Mabuchi, H. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00008 · Cited by 58
Chronic oat bran intake alters postprandial lipemia and lipoproteins in healthy adults
Dubois, C., Armand, M., Senft, M., Portugal, H., Pauli, A.-M., Bernard, P., Lafont, H., & Lairon, D. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.2.325 · Cited by 58
“(CETP)-mediated transfer of cholesterol esters to TRL ( 43 , 48),”
BackgroundResultInfluentialDifferential response to low-fat diet between low and normal HDL-cholesterol subjects
Asztalos, B. F., LeFevre, M. L., Wong, L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Zhang, W., & Roheim, P. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34470-9 · Cited by 57
Dubois, C., Armand, M., Mekki, N., Portugal, H., Pauli, A.-M., Bernard, P. M., Lafont, H., & Lairon, D. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39946-6 · Cited by 57
Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia
Maioli, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06095-4 · Cited by 56
HDLs, Diabetes, and Metabolic Syndrome
Vollenweider, P., von Eckardstein, A., & Widmann, C. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_12 · Cited by 55
“However, in individuals with hypertriglyceridemia, cholesteryl ester transfer from HDL to VLDL can be augmented by increasing CETP plasma activity (Mann et al. 1991).”
Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes
Khavandi, M., Duarte, F., Ginsberg, H. N., & Reyes‐Soffer, G. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0818-1 · Cited by 58
Frisdal, É., Klerkx, A. H. E. M., Goff, W. L., Tanck, M. W. T., Lagarde, J., Jukema, J. W., Kastelein, J. J. P., Chapman, M. J., & Guérin, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi291 · Cited by 54
“These dyslipidemic states are equally associated not only with elevated concentrations and activity of CETP in plasma (1,2), but also with low plasma high-density lipoprotein cholesterol (HDL-C) and apoAI levels (3,4).”
BackgroundPostprandial Lipemia and Remnant Lipoproteins
Cohn, J. S. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.003 · Cited by 55
Kark, J. D., Sinnreich, R., Leitersdorf, E., Friedlander, Y., Shpitzen, S., & Luc, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00408-6 · Cited by 54
Ahnadi, C.-E., Berthézène, F., & Ponsin, G. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90024-o · Cited by 54
CETP inhibition in cardiovascular risk management: a critical appraisal
Dullaart, R. P. F., Dallinga‐Thie, G. M., Wolffenbuttel, B. H. R., & van Tol, A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01756.x · Cited by 54
Bernard, S., Moulin, P., Lagrost, L., Picard, S., Elchebly, M., Ponsin, G., Chapuis, F. R., & Berthézène, F. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34203-6 · Cited by 54
Metadata
- Authors
- Mann, C. J., Yen, F. T., Grant, A. M., & Bihain, B. E.
- Affiliations
- Louisiana State University (US)
- ORCID
- Yen, F T
- Venue
- Journal of Clinical Investigation
- Published
- 1991-12-01
- Volume
- 88
- Issue
- 6
- Pages
- 2059-2066
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2114689977
- Cited by
- 339
- References
- 30
- Citations by year
- 2024: 5 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 10 · 2013: 1 · 2012: 2
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl025596-15)
- National Heart, Lung, and Blood Institute (HL255-96)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cholesteryl ester transfer, cholesteryl ester transfer protein, hypertriglyceridemia, VLDL, VLDL triglycerides, reverse cholesterol transport, CETP activity, bezafibrate, lipoprotein metabolism, rate-determining step
- MeSH terms
- Adult, Bezafibrate, Biological Transport, Carrier Proteins, Cholesterol Esters, Glycoproteins, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Triglycerides, Hypertriglyceridemia, Cholesterol Ester Transfer Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review